BeOne Medicines Recognized as Outstanding Global Oncology Company of the Year at HKCT Business Awards 2026
- Written by 百濟神州 BeOne Medicines
HONG KONG SAR - Media OutReach Newswire - 11 May 2026 - BeOne Medicines (BeOne, Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it has been named "Outstanding Global Oncology Company of the Year" at the HKCT Business Awards 2026. The award recognizes BeOne's continued progress in research and development...




